Overlap between neurodegenerative disorders

Richard A. Armstrong*, Peter L. Lantos, Nigel J. Cairns

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Neurodegenerative disorders are characterized by the formation of distinct pathological changes in the brain, including extracellular protein deposits, cellular inclusions, and changes in cell morphology. Since the earliest published descriptions of these disorders, diagnosis has been based on clinicopathological features, namely, the coexistence of a specific clinical profile together with the presence or absence of particular types of lesion. In addition, the molecular profile of lesions has become an increasingly important feature both in the diagnosis of existing disorders and in the description of new disease entities. Recent studies, however, have reported considerable overlap between the clinicopathological features of many disorders leading to difficulties in the diagnosis of individual cases and to calls for a new classification of neurodegenerative disease. This article discusses: (i) the nature and degree of the overlap between different neurodegenerative disorders and includes a discussion of Alzheimer's disease, dementia with Lewy bodies, the fronto-temporal dementias, and prion disease; (ii) the factors that contribute to disease overlap, including historical factors, the presence of disease heterogeneity, age-related changes, the problem of apolipoprotein genotype, and the co-occurrence of common diseases; and (iii) whether the current nosological status of disorders should be reconsidered.

Original languageEnglish
Pages (from-to)111-124
Number of pages14
JournalNeuropathology
Volume25
Issue number2
Early online date1 Apr 2005
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Neurodegenerative Diseases
Alzheimer Disease
Lewy Bodies
Prion Diseases
Apolipoproteins
Inclusion Bodies
Dementia
Genotype
Brain
Proteins

Keywords

  • α-synucleinopathy
  • brain lesion
  • disease heterogeneity
  • neurodegenerative disorder
  • nosology
  • tauopathy

Cite this

Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2005). Overlap between neurodegenerative disorders. Neuropathology, 25(2), 111-124. https://doi.org/10.1111/j.1440-1789.2005.00605.x
Armstrong, Richard A. ; Lantos, Peter L. ; Cairns, Nigel J. / Overlap between neurodegenerative disorders. In: Neuropathology. 2005 ; Vol. 25, No. 2. pp. 111-124.
@article{d941483ea57b4eae9d78be7359f14d60,
title = "Overlap between neurodegenerative disorders",
abstract = "Neurodegenerative disorders are characterized by the formation of distinct pathological changes in the brain, including extracellular protein deposits, cellular inclusions, and changes in cell morphology. Since the earliest published descriptions of these disorders, diagnosis has been based on clinicopathological features, namely, the coexistence of a specific clinical profile together with the presence or absence of particular types of lesion. In addition, the molecular profile of lesions has become an increasingly important feature both in the diagnosis of existing disorders and in the description of new disease entities. Recent studies, however, have reported considerable overlap between the clinicopathological features of many disorders leading to difficulties in the diagnosis of individual cases and to calls for a new classification of neurodegenerative disease. This article discusses: (i) the nature and degree of the overlap between different neurodegenerative disorders and includes a discussion of Alzheimer's disease, dementia with Lewy bodies, the fronto-temporal dementias, and prion disease; (ii) the factors that contribute to disease overlap, including historical factors, the presence of disease heterogeneity, age-related changes, the problem of apolipoprotein genotype, and the co-occurrence of common diseases; and (iii) whether the current nosological status of disorders should be reconsidered.",
keywords = "α-synucleinopathy, brain lesion, disease heterogeneity, neurodegenerative disorder, nosology, tauopathy",
author = "Armstrong, {Richard A.} and Lantos, {Peter L.} and Cairns, {Nigel J.}",
year = "2005",
month = "6",
doi = "10.1111/j.1440-1789.2005.00605.x",
language = "English",
volume = "25",
pages = "111--124",
journal = "Neuropathology",
issn = "0919-6544",
publisher = "Wiley-Blackwell",
number = "2",

}

Armstrong, RA, Lantos, PL & Cairns, NJ 2005, 'Overlap between neurodegenerative disorders', Neuropathology, vol. 25, no. 2, pp. 111-124. https://doi.org/10.1111/j.1440-1789.2005.00605.x

Overlap between neurodegenerative disorders. / Armstrong, Richard A.; Lantos, Peter L.; Cairns, Nigel J.

In: Neuropathology, Vol. 25, No. 2, 06.2005, p. 111-124.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Overlap between neurodegenerative disorders

AU - Armstrong, Richard A.

AU - Lantos, Peter L.

AU - Cairns, Nigel J.

PY - 2005/6

Y1 - 2005/6

N2 - Neurodegenerative disorders are characterized by the formation of distinct pathological changes in the brain, including extracellular protein deposits, cellular inclusions, and changes in cell morphology. Since the earliest published descriptions of these disorders, diagnosis has been based on clinicopathological features, namely, the coexistence of a specific clinical profile together with the presence or absence of particular types of lesion. In addition, the molecular profile of lesions has become an increasingly important feature both in the diagnosis of existing disorders and in the description of new disease entities. Recent studies, however, have reported considerable overlap between the clinicopathological features of many disorders leading to difficulties in the diagnosis of individual cases and to calls for a new classification of neurodegenerative disease. This article discusses: (i) the nature and degree of the overlap between different neurodegenerative disorders and includes a discussion of Alzheimer's disease, dementia with Lewy bodies, the fronto-temporal dementias, and prion disease; (ii) the factors that contribute to disease overlap, including historical factors, the presence of disease heterogeneity, age-related changes, the problem of apolipoprotein genotype, and the co-occurrence of common diseases; and (iii) whether the current nosological status of disorders should be reconsidered.

AB - Neurodegenerative disorders are characterized by the formation of distinct pathological changes in the brain, including extracellular protein deposits, cellular inclusions, and changes in cell morphology. Since the earliest published descriptions of these disorders, diagnosis has been based on clinicopathological features, namely, the coexistence of a specific clinical profile together with the presence or absence of particular types of lesion. In addition, the molecular profile of lesions has become an increasingly important feature both in the diagnosis of existing disorders and in the description of new disease entities. Recent studies, however, have reported considerable overlap between the clinicopathological features of many disorders leading to difficulties in the diagnosis of individual cases and to calls for a new classification of neurodegenerative disease. This article discusses: (i) the nature and degree of the overlap between different neurodegenerative disorders and includes a discussion of Alzheimer's disease, dementia with Lewy bodies, the fronto-temporal dementias, and prion disease; (ii) the factors that contribute to disease overlap, including historical factors, the presence of disease heterogeneity, age-related changes, the problem of apolipoprotein genotype, and the co-occurrence of common diseases; and (iii) whether the current nosological status of disorders should be reconsidered.

KW - α-synucleinopathy

KW - brain lesion

KW - disease heterogeneity

KW - neurodegenerative disorder

KW - nosology

KW - tauopathy

UR - http://www.scopus.com/inward/record.url?scp=17644422180&partnerID=8YFLogxK

UR - http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1789.2005.00605.x/abstract

U2 - 10.1111/j.1440-1789.2005.00605.x

DO - 10.1111/j.1440-1789.2005.00605.x

M3 - Article

C2 - 15875904

VL - 25

SP - 111

EP - 124

JO - Neuropathology

JF - Neuropathology

SN - 0919-6544

IS - 2

ER -